Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists.

OBJECTIVE Thyrotoxicosis has multiple etiologies, manifestations, and potential therapies. Appropriate treatment requires an accurate diagnosis and is influenced by coexisting medical conditions and patient preference. This article describes evidence-based clinical guidelines for the management of thyrotoxicosis that would be useful to generalist and subspeciality physicians and others providing care for patients with this condition. METHODS The development of these guidelines was commissioned by the American Thyroid Association in association with the American Association of Clinical Endocrinologists. The American Thyroid Association and American Association of Clinical Endocrinologists assembled a task force of expert clinicians who authored this report. The task force examined relevant literature using a systematic PubMed search supplemented with additional published materials. An evidence-based medicine approach that incorporated the knowledge and experience of the panel was used to develop the text and a series of specific recommendations. The strength of the recommendations and the quality of evidence supporting each was rated according to the approach recommended by the Grading of Recommendations, Assessment, Development, and Evaluation Group. RESULTS Clinical topics addressed include the initial evaluation and management of thyrotoxicosis; management of Graves' hyperthyroidism using radioactive iodine, antithyroid drugs, or surgery; management of toxic multinodular goiter or toxic adenoma using radioactive iodine or surgery; Graves' disease in children, adolescents, or pregnant patients; subclinical hyperthyroidism; hyperthyroidism in patients with Graves' ophthalmopathy; and management of other miscellaneous causes of thyrotoxicosis. CONCLUSIONS One hundred evidence-based recommendations were developed to aid in the care of patients with thyrotoxicosis and to share what the task force believes is current, rational, and optimal medical practice.

[1]  A. D. de Craen,et al.  Thyroid status, disability and cognitive function, and survival in old age. , 2004, JAMA.

[2]  R. Paschke,et al.  Genetics and phenomics of inherited and sporadic non-autoimmune hyperthyroidism , 2010, Molecular and Cellular Endocrinology.

[3]  D. Farley,et al.  Evidence-based Management of Toxic Multinodular Goiter (Plummer’s Disease) , 2008, World Journal of Surgery.

[4]  D. Bauer,et al.  Risk for Fracture in Women with Low Serum Levels of Thyroid-Stimulating Hormone , 2001, Annals of Internal Medicine.

[5]  J. Franklyn,et al.  Older subjects with hyperthyroidism present with a paucity of symptoms and signs: a large cross-sectional study. , 2010, The Journal of clinical endocrinology and metabolism.

[6]  A. Auvinen,et al.  Increased cancer incidence after radioiodine treatment for hyperthyroidism , 2007, Cancer.

[7]  G. Benker,et al.  Antithyroid drug — induced agranulocytosis: Clinical experience with ten patients treated at one institution and review of the literature , 1994, Journal of endocrinological investigation.

[8]  R. D'Agostino,et al.  Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. , 1994, The New England journal of medicine.

[9]  G. Saade,et al.  Pharmacokinetics and Pharmacotherapy of Thionamides in Pregnancy , 2006, Therapeutic drug monitoring.

[10]  E. Eugster,et al.  Time course to hypothyroidism after fixed-dose radioablation therapy of Graves' disease in children. , 2002, The Journal of pediatrics.

[11]  S. Gamba,et al.  Long-term follow-up of patients with hyperthyroidism due to Graves’ disease treated with methimazole. Comparison of usual treatment schedule with drug discontinuation vs continuous treatment with low methimazole doses: A retrospective study , 2008, Journal of endocrinological investigation.

[12]  P. Laurberg,et al.  Guidelines for TSH-receptor antibody measurements in pregnancy: results of an evidence-based symposium organized by the European Thyroid Association. , 1998, European journal of endocrinology.

[13]  P. Chanson,et al.  The changing spectrum of TSH-secreting pituitary adenomas: diagnosis and management in 43 patients. , 2003, European journal of endocrinology.

[14]  A. Weetman,et al.  Clinical experience of amiodarone‐induced thyrotoxicosis over a 3‐year period: role of colour‐flow Doppler sonography * , 2002, Clinical endocrinology.

[15]  D. Farley,et al.  Surgical Management of Amiodarone-associated Thyrotoxicosis: Mayo Clinic Experience , 2004, World Journal of Surgery.

[16]  Ross Ward,et al.  American Association of Clinical Endocrinologists , 2011 .

[17]  F. Bogazzi,et al.  Treatment of amiodarone-induced thyrotoxicosis, a difficult challenge: results of a prospective study. , 1996, The Journal of clinical endocrinology and metabolism.

[18]  C. Son,et al.  Diffuse Alveolar Hemorrhage Associated with Antineutrophil Cytoplasmic Antibody levels in a Pregnant Woman Taking Propylthiouracil , 2006, The Korean journal of internal medicine.

[19]  C. Reiners,et al.  Reduction in thyroid volume after radioiodine therapy of Graves' hyperthyroidism: results of a prospective, randomized, multicentre study , 1996, European journal of clinical investigation.

[20]  N. Morgenthaler,et al.  Thyrotropin receptor autoantibodies are independent risk factors for Graves' ophthalmopathy and help to predict severity and outcome of the disease. , 2006, The Journal of clinical endocrinology and metabolism.

[21]  P. Laurberg,et al.  Management of Graves' hyperthyroidism in pregnancy: focus on both maternal and foetal thyroid function, and caution against surgical thyroidectomy in pregnancy. , 2009, European journal of endocrinology.

[22]  R. Penne Thyroid-Associated Ophthalmopathy after Treatment for Graves' Hyperthyroidism with Antithyroid Drugs or Iodine-131 , 2010 .

[23]  J. Loré Surgery of the thyroid gland. , 1980, Otolaryngologic clinics of North America.

[24]  R. Wahl,et al.  Differentiated operative therapy of thyroid autonomy (Plummer's disease). , 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[25]  D. Ueda Normal volume of the thyroid gland in children , 1990, Journal of clinical ultrasound : JCU.

[26]  M. Tansey,et al.  A 36-year retrospective analysis of the efficacy and safety of radioactive iodine in treating young Graves' patients. , 2004, The Journal of clinical endocrinology and metabolism.

[27]  H. Gerstein How common is postpartum thyroiditis? A methodologic overview of the literature. , 1990, Archives of internal medicine.

[28]  E. de Juan,et al.  Racial differences in normal values of proptosis. , 1980, Archives of internal medicine.

[29]  A Hofman,et al.  Subclinical hyperthyroidism and the risk of dementia. The Rotterdam study , 2000, Clinical endocrinology.

[30]  J. Romaldini,et al.  Propylthiouracil reduces the effectiveness of radioiodine treatment in hyperthyroid patients with Graves' disease. , 2004, Thyroid : official journal of the American Thyroid Association.

[31]  Chao Ma,et al.  Radioiodine treatment for pediatric Graves' disease. , 2008, The Cochrane database of systematic reviews.

[32]  S. Zakavi,et al.  Comparison of four different protocols of I-131 therapy for treating single toxic thyroid nodule , 2009, Nuclear medicine communications.

[33]  D. Farley,et al.  Surgical management of Graves disease in childhood and adolescence: an institutional experience. , 2006, Surgery.

[34]  L. Jacobsson,et al.  Radioiodine treatment of hyperthyroidism in a pregnant women. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[35]  R. Siegel,et al.  Toxic nodular goiter. Toxic adenoma and toxic multinodular goiter. , 1998, Endocrinology and metabolism clinics of North America.

[36]  S. Nagataki,et al.  Differences and similarities in the diagnosis and treatment of Graves' disease in Europe, Japan, and the United States. , 1991, Thyroid : official journal of the American Thyroid Association.

[37]  Elementary school performance of children with congenital hypothyroidism. New England Congenital Hypothyroidism Collaborative. , 1990, The Journal of pediatrics.

[38]  P. Vitti,et al.  Could improved ultrasound and power Doppler replace thyroidal radioiodine uptake to assess thyroid disease? , 2007, Nature Clinical Practice Endocrinology &Metabolism.

[39]  J. Franklyn,et al.  Thyroid function and mortality in patients treated for hyperthyroidism. , 2005, JAMA.

[40]  A. Avenell,et al.  Antithyroid drug regimen for treating Graves' hyperthyroidism. , 2010, The Cochrane database of systematic reviews.

[41]  V. Trischitta,et al.  Percutaneous ethanol injection plus radioiodine versus radioiodine alone in the treatment of large toxic thyroid nodules. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[42]  E. Martino,et al.  Diagnosis and treatment of thyrotoxicosis in childhood. A European questionnaire study. , 1994, European journal of endocrinology.

[43]  E. Roti,et al.  Post-partum thyroiditis--a clinical update. , 2002, European journal of endocrinology.

[44]  S. Rivkees,et al.  An optimal treatment for pediatric Graves' disease is radioiodine. , 2007, The Journal of clinical endocrinology and metabolism.

[45]  E. Mazzaferri,et al.  Sensitivity, specificity, and cost-effectiveness of the sensitive thyrotropin assay in the diagnosis of thyroid disease in ambulatory patients. , 1989, Archives of internal medicine.

[46]  L. Rubert,et al.  Meta-variability of advice on drugs in the breastfeeding mother: the example of β-blockers , 2008, Archives of Disease in Childhood Fetal and Neonatal Edition.

[47]  L. Delbridge,et al.  Age is no contraindication to thyroid surgery. , 1999, Age and ageing.

[48]  S. Noguchi,et al.  Antithyroid drug-induced agranulocytosis: how has granulocyte colony-stimulating factor changed therapy? , 2005, Thyroid : official journal of the American Thyroid Association.

[49]  F. Martin,et al.  A prospective study of the effect of nonionic contrast media on thyroid function. , 1996, Thyroid : official journal of the American Thyroid Association.

[50]  P. Crowe,et al.  Hypomagnesemia and Hypocalcemia after Thyroidectomy: Prospective Study , 2000, World Journal of Surgery.

[51]  L. Braverman,et al.  COMPARISON OF METHIMAZOLE, METHIMAZOLE AND SODIUM IPODATE, AND METHIMAZOLE AND SATURATED SOLUTION OF POTASSIUM IODIDE IN THE EARLY TREATMENT OF HYPERTHYROID GRAVES’DISEASE , 1988, Clinical endocrinology.

[52]  P. Woolf Transient painless thyroiditis with hyperthyroidism: a variant of lymphocytic thyroiditis? , 1980, Endocrine reviews.

[53]  V. Simha,et al.  Antineutrophil cytoplasmic antibody-positive vasculitis in a patient with graves disease: cross-reaction between propylthiouracil and methimazole. , 2010, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[54]  W. Wiersinga,et al.  Frequency and characteristics of TBII‐seronegative patients in a population with untreated Graves’ hyperthyroidism: a prospective study , 2008, Clinical endocrinology.

[55]  Rosalind S. Brown,et al.  Persistence of thyrotropin (TSH) receptor antibodies in children and adolescents with Graves' disease treated using antithyroid medication. , 2007, Thyroid : official journal of the American Thyroid Association.

[56]  B. Goichot,et al.  Antithyroid drugs , 2005, The New England journal of medicine.

[57]  D. Becker,et al.  Complications of radioiodine treatment of hyperthyroidism. , 1971, Seminars in nuclear medicine.

[58]  P. Ladenson,et al.  Agranulocytosis associated with antithyroid drugs. Effects of patient age and drug dose. , 1983, Annals of internal medicine.

[59]  L. Holm,et al.  Incidence of hypothyroidism occurring long after iodine-131 therapy for hyperthyroidism. , 1982, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[60]  B. M. Dobyns,et al.  Malignant and benign neoplasms of the thyroid in patients treated for hyperthyroidism: a report of the cooperative thyrotoxicosis therapy follow-up study. , 1974, The Journal of clinical endocrinology and metabolism.

[61]  M. Nardi,et al.  Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy. , 1998, The New England journal of medicine.

[62]  W. Fisher,et al.  Congenital hypothyroidism in infant following maternal I131 therapy , 1963 .

[63]  T. Reeve,et al.  The Preferred Option for Multinodular Goiter , 1987 .

[64]  C. Gorman,et al.  Radioiodine and pregnancy. , 1999, Thyroid : official journal of the American Thyroid Association.

[65]  S. Rivkees,et al.  Clinical and economic outcomes of thyroid and parathyroid surgery in children. , 2008, The Journal of clinical endocrinology and metabolism.

[66]  Yan Liu,et al.  Primary thyroid cancer after a first tumour in childhood (the Childhood Cancer Survivor Study): a nested case-control study , 2005, The Lancet.

[67]  C. Lombardi,et al.  Is routine supplementation therapy (calcium and vitamin D) useful after total thyroidectomy? , 2002, Surgery.

[68]  G. Burrow,et al.  Thyrotoxicosis in Pregnancy , 1991 .

[69]  G. Bifulco,et al.  Reduced bone mass detected by bone quantitative ultrasonometry and DEXA in pre- and postmenopausal women with endogenous subclinical hyperthyroidism. , 2004, Maturitas.

[70]  L. Giovanella Increased cancer incidence after radioiodine treatment for hyperthyroidism , 2008, Cancer.

[71]  A. Kruseman,et al.  Bone metabolism during anti‐thyroid drug treatment of endogenous subclinical hyperthyroidism , 1994, Clinical endocrinology.

[72]  E. Salpeter,et al.  Cardioselective -Blockers in Patients with Reactive Airway Disease , 2002, Annals of Internal Medicine.

[73]  J. Brosseau,et al.  Lymphocytic thyroiditis with spontaneously resolving hyperthyroidism (silent thyroiditis). , 1980, Archives of internal medicine.

[74]  L. Braverman,et al.  Free T4 immunoassays are flawed during pregnancy. , 2009, American journal of obstetrics and gynecology.

[75]  Dolphin Gw The risk of thyroid cancers following irradiation. , 1968 .

[76]  J. Feely,et al.  Beta‐adrenoceptor blockade and anaesthesia for thyroidectomy , 1984, Anaesthesia.

[77]  M. Prummel,et al.  Effect of abnormal thyroid function on the severity of Graves' ophthalmopathy. , 1990, Archives of internal medicine.

[78]  M. Weiss,et al.  [Thyrotoxicosis in pregnancy]. , 1979, Harefuah.

[79]  J. Korf,et al.  Clinical significance of probenecid test. , 1973, Lancet.

[80]  P. Gruppuso,et al.  Thyroid storm in a child following radioactive iodine (RAI) therapy: a consequence of RAI versus withdrawal of antithyroid medication. , 2001, The Journal of clinical endocrinology and metabolism.

[81]  S. Rivkees Graves' disease therapy in children: truth and inevitable consequences. , 2007, Journal of pediatric endocrinology & metabolism : JPEM.

[82]  W. Wiersinga,et al.  Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy , 1997, Clinical endocrinology.

[83]  R. Toohey,et al.  The AAPM/RSNA physics tutorial for residents: internal radiation dosimetry: principles and applications. , 2000, Radiographics : a review publication of the Radiological Society of North America, Inc.

[84]  A. Pinchera,et al.  Impact of lithium on efficacy of radioactive iodine therapy for Graves' disease: a cohort study on cure rate, time to cure, and frequency of increased serum thyroxine after antithyroid drug withdrawal. , 2010, The Journal of clinical endocrinology and metabolism.

[85]  I. Mcdougall,et al.  How should the dose of iodine-131 be determined in the treatment of Graves' hyperthyroidism? , 2003, The Journal of clinical endocrinology and metabolism.

[86]  D. Shulman,et al.  Autoimmune hyperthyroidism in prepubertal children and adolescents: comparison of clinical and biochemical features at diagnosis and responses to medical therapy. , 1997, Thyroid : official journal of the American Thyroid Association.

[87]  A. Casolaro,et al.  Five‐year follow‐up of percutaneous ethanol injection for the treatment of hyperfunctioning thyroid nodules: a study of 117 patients , 1997, Clinical endocrinology.

[88]  J. Dashe,et al.  Subclinical Hyperthyroidism and Pregnancy Outcomes , 2006, Obstetrics and gynecology.

[89]  D. Cooper Antithyroid drugs in the management of patients with Graves' disease: an evidence-based approach to therapeutic controversies. , 2003, The Journal of clinical endocrinology and metabolism.

[90]  C. Alessi,et al.  Low serum free thyroxine index in ambulating elderly is due to a resetting of the threshold of thyrotropin feedback suppression. , 1991, The Journal of clinical endocrinology and metabolism.

[91]  A. Pinchera,et al.  Testicular function after 131I therapy for hyperthyroidism , 2006, Clinical endocrinology.

[92]  R. Carretta,et al.  The increasing incidence of hypothyroidism within one year after radioiodine therapy for toxic diffuse goiter. , 1978, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[93]  J. Magner Problems associated with the use of thyrogen in patients with a thyroid gland. , 2008, The New England journal of medicine.

[94]  P. Laurberg,et al.  Interferon-alpha and autoimmune thyroid disease. , 2003, Thyroid : official journal of the American Thyroid Association.

[95]  D. Steward,et al.  The Role of Rapid Pacu Parathyroid Hormone in Reducing Post-Thyroidectomy Hypocalcemia , 2009, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[96]  P. Libby,et al.  Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 2-Volume Set, 9th Edition Expert Consult Premium Edition €“ Enhanced Online Features , 2011 .

[97]  E. Eugster Predictors of autoimmune hyperthyroidism relapse in children after discontinuation of antithyroid drug treatment , 2009 .

[98]  J. Greenhouse,et al.  A psychiatric and neuropsychological study of patients with untreated Graves' disease. , 1988, General hospital psychiatry.

[99]  C. Haffajee,et al.  Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy. , 1984, Annals of internal medicine.

[100]  C. Miller,et al.  The efficacy of thyroidectomy for Graves' disease: A meta-analysis. , 2000, The Journal of surgical research.

[101]  Burchell Hb,et al.  Thyroid cancer yield in patients with Graves' disease. , 2003 .

[102]  S. Mandel,et al.  Are detection and treatment of thyroid insufficiency in pregnancy feasible? , 2005, Thyroid : official journal of the American Thyroid Association.

[103]  J. Nicoloff,et al.  Applications of a new chemiluminometric thyrotropin assay to subnormal measurement. , 1990, The Journal of clinical endocrinology and metabolism.

[104]  G. Geelhoed Surgery of the endocrine glands in pregnancy. , 1983, Clinical obstetrics and gynecology.

[105]  M. Doody,et al.  Cancer Mortality Following Treatment for Adult Hyperthyroidism , 1998 .

[106]  C. Sempoux,et al.  Propylthiouracyl-induced severe liver toxicity: an indication for alanine aminotransferase monitoring? , 2006, World journal of gastroenterology.

[107]  M. Briel,et al.  Effects of antithyroid drugs on radioiodine treatment: systematic review and meta-analysis of randomised controlled trials , 2007, BMJ : British Medical Journal.

[108]  J. H. Schade,et al.  Clinical and biochemical changes following 131I therapy for hyperthyroidism in patients not pretreated with antithyroid drugs. , 1999, The Netherlands journal of medicine.

[109]  M. Minuto,et al.  Doppler evaluation of intrathyroid arterial resistances during preoperative treatment with Lugol's iodide solution in patients with diffuse toxic goiter. , 2000, Journal of the American College of Surgeons.

[110]  D. Luton,et al.  Fetal and neonatal thyroid function in relation to maternal Graves' disease. , 2004, Best practice & research. Clinical endocrinology & metabolism.

[111]  Stephanie L. Lee,et al.  Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. , 2009, Thyroid : official journal of the American Thyroid Association.

[112]  J. Ruiz,et al.  Fulminant Hepatic Failure Associated with Propylthiouracil , 2003, The Annals of pharmacotherapy.

[113]  K. Nair,et al.  Changes in skeletal muscle protein metabolism and myosin heavy chain isoform messenger ribonucleic acid abundance after treatment of hyperthyroidism. , 2006, The Journal of clinical endocrinology and metabolism.

[114]  Kunihiko Ito,et al.  Clinical characteristics of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis caused by antithyroid drugs. , 2009, The Journal of clinical endocrinology and metabolism.

[115]  J. Franklyn,et al.  Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study , 2001, The Lancet.

[116]  N. Qvist,et al.  Experience in a specialist thyroid surgery unit: a demographic study, surgical complications, and outcome. , 1997, The European journal of surgery = Acta chirurgica.

[117]  Per Hall,et al.  Thyroid cancer risk after thyroid examination with 131I: A population‐based cohort study in Sweden , 2003, International journal of cancer.

[118]  W. Wiersinga,et al.  Interrelationships between age, thyroid volume, thyroid nodularity, and thyroid function in patients with sporadic nontoxic goiter. , 1990, The American journal of medicine.

[119]  J H Lubin,et al.  Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. , 1995, Radiation research.

[120]  P. Blanc,et al.  Lasting remissions in patients treated for Graves' hyperthyroidism with propranolol alone: a pattern of spontaneous evolution of the disease. , 1988, The Journal of clinical endocrinology and metabolism.

[121]  M. Surks,et al.  Drugs and thyroid function. , 1995, The New England journal of medicine.

[122]  J. Franklyn,et al.  Is Subclinical Thyroid Dysfunction in the Elderly Associated with Depression or Cognitive Dysfunction? , 2006, Annals of Internal Medicine.

[123]  G. Daniels,et al.  Association between lithium use and thyrotoxicosis caused by silent thyroiditis , 2001, Clinical endocrinology.

[124]  A. Madec,et al.  Reduction of the risk of relapse after withdrawal of medical therapy for Graves' disease. , 2002, Thyroid : official journal of the American Thyroid Association.

[125]  A. Stojadinovic,et al.  The use of rapid parathyroid hormone assay in predicting postoperative hypocalcemia after total or completion thyroidectomy. , 2006, Thyroid : official journal of the American Thyroid Association.

[126]  L. Bartalena,et al.  Lower dose prednisone prevents radioiodine-associated exacerbation of initially mild or absent graves' orbitopathy: a retrospective cohort study. , 2010, The Journal of clinical endocrinology and metabolism.

[127]  G. Thompson,et al.  Current treatment of nodular goiter with hyperthyroidism (Plummer's disease): surgery versus radioiodine. , 2002, Surgery.

[128]  K. Nair,et al.  Changes in body composition in women following treatment of overt and subclinical hyperthyroidism. , 2008, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[129]  N. Paunković,et al.  Does Autoantibody-negative Graves’ Disease Exist? A Second Evaluation of the Clinical Diagnosis , 2006, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[130]  A. L'Abbate,et al.  Association between increased mortality and mild thyroid dysfunction in cardiac patients. , 2007, Archives of internal medicine.

[131]  S. Roman,et al.  Racial Disparities in Clinical and Economic Outcomes From Thyroidectomy , 2007, Annals of surgery.

[132]  Shing M. Lee,et al.  Thyroidectomy using local anesthesia: a report of 1,025 cases over 16 years. , 2005, Journal of the American College of Surgeons.

[133]  R. Howard,et al.  The effect of antithyroid drug pretreatment on acute changes in thyroid hormone levels after (131)I ablation for Graves' disease. , 2001, The Journal of clinical endocrinology and metabolism.

[134]  K. Woeber Observations concerning the natural history of subclinical hyperthyroidism. , 2005, Thyroid : official journal of the American Thyroid Association.

[135]  B. Hamberger,et al.  Graves' disease: a long-term quality-of-life follow up of patients randomized to treatment with antithyroid drugs, radioiodine, or surgery. , 2005, Thyroid : official journal of the American Thyroid Association.

[136]  P. Larsen,et al.  Maternal and Fetal Thyroid Function , 1994 .

[137]  J. Mckenzie,et al.  Pregnancy-associated changes in the thyroid-stimulating antibody of Graves' disease and the relationship to neonatal hyperthyroidism. , 1983, The Journal of clinical endocrinology and metabolism.

[138]  J. Dötsch,et al.  Graves Disease in Childhood , 2003, Paediatric drugs.

[139]  J. Díez Hyperthyroidism in Patients Older than 55 Years: An Analysis of the Etiology and Management , 2003, Gerontology.

[140]  J. Marving,et al.  Resumption of methimazole after 131I therapy of hyperthyroid diseases: effect on thyroid function and volume evaluated by a randomized clinical trial. , 2003, European journal of endocrinology.

[141]  L. Hegedüs,et al.  Radioiodine therapy for multinodular toxic goiter. , 1999, Archives of internal medicine.

[142]  A. Kessler,et al.  Hypothyroidism following partial thyroidectomy , 2008, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[143]  S. Rivkees,et al.  Influence of iodine-131 dose on the outcome of hyperthyroidism in children. , 2003, Pediatrics.

[144]  R. Shore,et al.  Issues and epidemiological evidence regarding radiation-induced thyroid cancer. , 1992, Radiation research.

[145]  K. Heller,et al.  Re‐operation for bleeding after thyroidectomy and parathyroidectomy , 2001, Head & neck.

[146]  P. Leedman,et al.  Subclinical thyroid dysfunction and blood pressure: a community‐based study , 2006, Clinical endocrinology.

[147]  L. Fried,et al.  Thyroid status, cardiovascular risk, and mortality in older adults. , 2006, JAMA.

[148]  A. Taube,et al.  Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. The Thyroid Study Group. , 1992, The New England journal of medicine.

[149]  C. Salmaso,et al.  Use of an artificial neural network to predict Graves’ disease outcome within 2 years of drug withdrawal , 2004, European journal of clinical investigation.

[150]  J. Aguayo,et al.  Rapid preoperative preparation in hyperthyroidism , 1991, Clinical endocrinology.

[151]  M. Mossanen,et al.  An Algorithm Informed by the Parathyroid Hormone Level Reduces Hypocalcemic Complications of Thyroidectomy , 2010, World Journal of Surgery.

[152]  B. Biondi,et al.  Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients. , 2000, The Journal of clinical endocrinology and metabolism.

[153]  J. Lazarus,et al.  Aetiology of hyperthyroidism in Canada and Wales. , 1983, Journal of epidemiology and community health.

[154]  J. Boice Thyroid disease 60 years after Hiroshima and 20 years after Chernobyl. , 2006, JAMA.

[155]  L. Braverman,et al.  Multiple changes in thyroid function in patients with chronic active HCV hepatitis treated with recombinant interferon-alpha. , 1996, The American journal of medicine.

[156]  M. Castellano,et al.  The role of imaging in Graves' disease: a cost-effectiveness analysis. , 2008, European journal of radiology.

[157]  U. Burkhardt,et al.  Risk of iodine-induced thyrotoxicosis after coronary angiography: an investigation in 788 unselected subjects. , 1999, European journal of endocrinology.

[158]  J. Hershman Human chorionic gonadotropin and the thyroid: hyperemesis gravidarum and trophoblastic tumors. , 1999, Thyroid : official journal of the American Thyroid Association.

[159]  R. Ziegler,et al.  Smoking and endocrine ophthalmopathy: impact of smoking severity and current vs lifetime cigarette consumption , 1996, Clinical endocrinology.

[160]  A. Pinchera,et al.  Outcome of radioiodine‐131 therapy in hyperfunctioning thyroid nodules: a 20 years’ retrospective study , 2005, Clinical endocrinology.

[161]  P. Ladenson,et al.  Treatment guidelines for patients with hyperthyroidism and hypothyroidism. Standards of Care Committee, American Thyroid Association. , 1995, JAMA.

[162]  D. Bauer,et al.  Meta-analysis: Subclinical Thyroid Dysfunction and the Risk for Coronary Heart Disease and Mortality , 2008, Annals of Internal Medicine.

[163]  H. Gharib,et al.  Treatment of patients with toxic multinodular goiter. , 1998, Thyroid : official journal of the American Thyroid Association.

[164]  A. Avenell,et al.  A systematic review of drug therapy for Graves' hyperthyroidism. , 2005, European journal of endocrinology.

[165]  A. Chang,et al.  Habit cough, tic cough, and psychogenic cough in adult and pediatric populations: ACCP evidence-based clinical practice guidelines. , 2006, Chest.

[166]  M. Nardi,et al.  Consensus statement of the European group on Graves' orbitopathy (EUGOGO) on management of Graves' orbitopathy. , 2008, Thyroid : official journal of the American Thyroid Association.

[167]  C. Reiners,et al.  Treatment of Graves' hyperthyroidism with radioiodine: results of a prospective randomized study. , 1997, Thyroid : official journal of the American Thyroid Association.

[168]  D. Styne,et al.  Predicting the Likelihood of Remission in Children With Graves’ Disease: A Prospective, Multicenter Study , 2008, Pediatrics.

[169]  G. Lundell,et al.  Incidence of hyperthyroidism in Stockholm, Sweden, 2003-2005. , 2008, European journal of endocrinology.

[170]  J. Orcutt,et al.  Graves' ophthalmopathy. , 1992, The Western journal of medicine.

[171]  W. Roberts,et al.  Method specific second-trimester reference intervals for thyroid-stimulating hormone and free thyroxine. , 2009, Clinical biochemistry.

[172]  Beata Wojtczak,et al.  Influence of Total Thyroidectomy on Orbital Opthalmopathy and Levels of Antithyroid Antibodies in Patients with Graves' Disease , 2007 .

[173]  P. Colman,et al.  Iodine-induced hyperthyroidism due to nonionic contrast radiography in the elderly. , 1993, The American journal of medicine.

[174]  J. Franklyn,et al.  Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. , 2004, JAMA.

[175]  A. Pinchera,et al.  Surgical treatment of Graves' disease: subtotal or total thyroidectomy? , 1996, Surgery.

[176]  M. Yeh,et al.  PARATHYROID HORMONE ASSAY PREDICTS HYPOCALCAEMIA AFTER TOTAL THYROIDECTOMY , 2007, ANZ journal of surgery.

[177]  R. Yeatts Quality of life in patients with Graves ophthalmopathy. , 2006, Transactions of the American Ophthalmological Society.

[178]  Carlos Roberto Jaén,et al.  A clinical blueprint to accelerate the elimination of tobacco use. , 2008, JAMA.

[179]  M. Mori,et al.  Treatment for childhood-onset Graves' disease in Japan: results of a nationwide questionnaire survey of pediatric endocrinologists and thyroidologists. , 2007, Thyroid : official journal of the American Thyroid Association.

[180]  G. Guyatt,et al.  A case for clarity, consistency, and helpfulness: state-of-the-art clinical practice guidelines in endocrinology using the grading of recommendations, assessment, development, and evaluation system. , 2008, The Journal of clinical endocrinology and metabolism.

[181]  J. O'Loughlin,et al.  Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials , 2008, Canadian Medical Association Journal.

[182]  B. Senior,et al.  Iodide goiter in the newborn. , 1971, Pediatrics.

[183]  W. Wiersinga,et al.  Prediction of post partum thyroid dysfunction: can it be improved? , 1998, European journal of endocrinology.

[184]  D. Swanson,et al.  Iodine-131: optimal therapy for hyperthyroidism in children and adolescents? , 1979, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[185]  J. Rastad,et al.  Graves' disease with moderate-severe endocrine ophthalmopathy-long term results of a prospective, randomized study of total or subtotal thyroid resection. , 2005, Thyroid : official journal of the American Thyroid Association.

[186]  A. Kriplani,et al.  Maternal and perinatal outcome in thyrotoxicosis complicating pregnancy. , 1994, European journal of obstetrics, gynecology, and reproductive biology.

[187]  M. Goodarzi,et al.  Thyrotoxicosis in a male patient associated with excess human chorionic gonadotropin production by germ cell tumor. , 2000, Thyroid : official journal of the American Thyroid Association.

[188]  D. Glinoer,et al.  Effects of l-thyroxine administration, TSH-receptor antibodies and smoking on the risk of recurrence in Graves' hyperthyroidism treated with antithyroid drugs: a double-blind prospective randomized study. , 2001, European journal of endocrinology.

[189]  G. Dolphin The risk of thyroid cancers following irradiation. , 1968, Health physics.

[190]  S. Woodings Radiation protection recommendations for I-131 thyrotoxicosis, thyroid cancer and phaeochromocytoma patients , 2004, Australasian Physics & Engineering Sciences in Medicine.

[191]  M. Phillip,et al.  Thyrotoxicosis in prepubertal children compared with pubertal and postpubertal patients. , 2000, The Journal of clinical endocrinology and metabolism.

[192]  A. Morris,et al.  Serum thyroid-stimulating hormone concentration and morbidity from cardiovascular disease and fractures in patients on long-term thyroxine therapy. , 2010, The Journal of clinical endocrinology and metabolism.

[193]  Paolo Vitti,et al.  American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules: executive summary of recommendations. , 2010, Journal of endocrinological investigation.

[194]  Stephanie L. Lee,et al.  Prediction of hypocalcemia after using 1‐ to 6‐hour postoperative parathyroid hormone and calcium levels: An analysis of pooled individual patient data from 3 observational studies , 2009, Head & neck.

[195]  P. Vos,et al.  The measurement of fecal thyroxine in the diagnosis of thyrotoxicosis factitia. , 1993, Thyroid : official journal of the American Thyroid Association.

[196]  W. Hsu,et al.  Exophthalmos of patients with Graves' disease in Chinese of Taiwan , 2006, Eye.

[197]  E. Mazzaferri,et al.  Sensitivity, Specificity, and Cost-effectiveness of the Sensitive Thyrotropin Assay in the Diagnosis of Thyroid Disease in Ambulatory Patients , 1989 .

[198]  M. Cakir,et al.  Incidental Thyroid Carcinoma in Thyrotoxic Patients Treated by Surgery , 2006, Hormone Research in Paediatrics.

[199]  D. Cooper,et al.  Amiodarone and the thyroid. , 2005, The American journal of medicine.

[200]  F. Andersohn,et al.  Systematic Review: Agranulocytosis Induced by Nonchemotherapy Drugs , 2007, Annals of Internal Medicine.

[201]  J. Roh,et al.  Routine oral calcium and vitamin D supplements for prevention of hypocalcemia after total thyroidectomy. , 2006, American journal of surgery.

[202]  J. Jonklaas,et al.  Trimester-specific changes in maternal thyroid hormone, thyrotropin, and thyroglobulin concentrations during gestation: trends and associations across trimesters in iodine sufficiency. , 2004, Thyroid : official journal of the American Thyroid Association.

[203]  O. P. Schumacher,et al.  Treatment of childhood Graves' disease. A review with emphasis on radioiodine treatment. , 1988, Cleveland Clinic journal of medicine.

[204]  D. Dazzi,et al.  Graves' orbitopathy activation after radioactive iodine therapy with and without steroid prophylaxis. , 2009, The Journal of clinical endocrinology and metabolism.

[205]  H. Blomgren,et al.  Does early administration of thyroxine reduce the development of Graves' ophthalmopathy after radioiodine treatment? , 1994, European journal of endocrinology.

[206]  A. Hisham,et al.  Total thyroidectomy: the procedure of choice for multinodular goitre. , 2001, The European journal of surgery = Acta chirurgica.

[207]  C. Franceschi,et al.  Complex alteration of thyroid function in healthy centenarians. , 1993, The Journal of clinical endocrinology and metabolism.

[208]  A. Maia,et al.  Effect of methimazole pretreatment on serum thyroid hormone levels after radioactive treatment in Graves' hyperthyroidism. , 1999, The Journal of clinical endocrinology and metabolism.

[209]  H. Burch,et al.  Amiodarone-Induced Thyroid Dysfunction , 1999 .

[210]  L Koornneef,et al.  Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach. , 1989, The British journal of ophthalmology.

[211]  M. González-Ortiz,et al.  Remission of Graves' hyperthyroidism treated with methimazole. , 2002, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion.

[212]  L. Hegedüs,et al.  The feasibility of high dose iodine 131 treatment as an alternative to surgery in patients with a very large goiter: effect on thyroid function and size and pulmonary function. , 1999, The Journal of clinical endocrinology and metabolism.

[213]  D. Ross Syndromes of thyrotoxicosis with low radioactive iodine uptake. , 1998, Endocrinology and metabolism clinics of North America.

[214]  M. Mcdermott,et al.  New American Thyroid Association and American Association of Clinical Endocrinologists guidelines for thyrotoxicosis and other forms of hyperthyroidism: significant progress for the clinician and a guide to future research. , 2011, Thyroid : official journal of the American Thyroid Association.

[215]  Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves' disease. , 1999, The Journal of clinical endocrinology and metabolism.

[216]  A. Corrias,et al.  Factors at Onset Predictive of Lasting Remission in Paediatric Patients with Graves' Disease Followed for at Least Three Years , 1999, Journal of pediatric endocrinology & metabolism : JPEM.

[217]  F. Martin,et al.  Hyperthyroidism in elderly hospitalised patients: Clinical features and treatment outcomes , 1996, The Medical journal of Australia.

[218]  B. Velkeniers,et al.  Subclinical thyroid dysfunction and mortality: an estimate of relative and absolute excess all-cause mortality based on time-to-event data from cohort studies. , 2008, European journal of endocrinology.

[219]  Nicholas Wc,et al.  Single Daily Dose of Methimazole Compared to Every 8 Hours Propylthiouracil in the Treatment of Hyperthyroidism , 1995 .

[220]  L. Hegedüs,et al.  Transition of nodular toxic goiter to autoimmune hyperthyroidism triggered by 131I therapy. , 1999, Thyroid : official journal of the American Thyroid Association.

[221]  Stephanie L. Lee,et al.  Early prediction of hypocalcemia after thyroidectomy using parathyroid hormone: an analysis of pooled individual patient data from nine observational studies. , 2007, Journal of the American College of Surgeons.

[222]  P. Laurberg,et al.  Goitre size and outcome of medical treatment of Graves' disease. , 1986, Acta endocrinologica.

[223]  H. Mashiba,et al.  Lower serum free thyroxine (T4) levels in painless thyroiditis compared with Graves' disease despite similar serum total T4 levels. , 1987, The Journal of clinical endocrinology and metabolism.

[224]  N. Kapucuoglu,et al.  Thyroid cancer in toxic and non-toxic multinodular goiter. , 2007, Journal of postgraduate medicine.

[225]  R. Monson,et al.  Cancer mortality in women with thyroid disease. , 1990, Cancer research.

[226]  H. Issever,et al.  Effect of lugol solution on thyroid gland blood flow and microvessel density in the patients with Graves' disease. , 2007, The Journal of clinical endocrinology and metabolism.

[227]  S. Roman,et al.  Outcomes following thyroid and parathyroid surgery in pregnant women. , 2009, Archives of surgery.

[228]  M. Akmal,et al.  Radioiodine dosimetry in patients with end-stage renal disease receiving continuous ambulatory peritoneal dialysis therapy. , 2000, The Journal of clinical endocrinology and metabolism.

[229]  L. Hegedüs,et al.  Long‐term effect of radioactive iodine on thyroid function and size in patients with solitary autonomously functioning toxic thyroid nodules , 1999, Clinical endocrinology.

[230]  C. Terwee,et al.  Development of a disease specific quality of life questionnaire for patients with Graves’ ophthalmopathy: the GO-QOL , 2022 .

[231]  J. Franklyn,et al.  Age and gender predict the outcome of treatment for Graves' hyperthyroidism. , 2000, The Journal of clinical endocrinology and metabolism.

[232]  D. Styne,et al.  Predictors of early remission of hyperthyroidism in children. , 1997 .

[233]  S. Pearce,et al.  What is the evidence behind the evidence-base? The premature death of block-replace antithyroid drug regimens for Graves' disease. , 2006, European journal of endocrinology.

[234]  H. Yamashita,et al.  Prognosis of small thyroid cancer in patients with Graves' disease , 2006, The British journal of surgery.

[235]  A. McElduff,et al.  Prevalence of positive anti-neutrophil cytoplasmic antibody (ANCA) in patients receiving anti-thyroid medication. , 2000, European journal of endocrinology.

[236]  E. Reschini,et al.  Treatment of the autonomous thyroid nodule: a review. , 1996, European journal of endocrinology.

[237]  S. Bandinelli,et al.  Thyroid Function Abnormalities and Cognitive Impairment in Elderly People: Results of the Invecchiare in Chianti Study , 2009, Journal of the American Geriatrics Society.

[238]  A. Weetman Graves' hyperthyroidism: how long should antithyroid drug therapy be continued to achieve remission? , 2006, Nature Clinical Practice Endocrinology &Metabolism.

[239]  O. Tørring,et al.  TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study. , 2008, European journal of endocrinology.

[240]  B. Hoffman,et al.  Free thyroxine reference interval in each trimester of pregnancy determined with the Roche Modular E-170 electrochemiluminescent immunoassay. , 2008, Clinical biochemistry.

[241]  Richard Hellman,et al.  American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. , 2002, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[242]  S. Mishra,et al.  Total Thyroidectomy for Benign Thyroid Disorders in an Endemic Region , 2000, World Journal of Surgery.

[243]  M. Surks,et al.  Thyrotoxicosis in the very old. , 1986, The American journal of medicine.

[244]  P. Wilson,et al.  Low serum thyrotropin (thyroid-stimulating hormone) in older persons without hyperthyroidism. , 1991, Archives of internal medicine.

[245]  J. Mehlsen,et al.  Haemodynamic changes following treatment of subclinical and overt hyperthyroidism. , 2001, European journal of endocrinology.

[246]  F. B. Davis,et al.  Hyperthyroidism in patients over the age of 60 years. Clinical features in 85 patients. , 1974, Medicine.

[247]  N. Foulds,et al.  Antenatal carbimazole and choanal atresia: a new embryopathy. , 2006, Archives of otolaryngology--head & neck surgery.

[248]  J. Romaldini,et al.  Highlights of the guidelines on the management of hyperthyroidism and other causes of thyrotoxicosis. , 2011, Thyroid : official journal of the American Thyroid Association.

[249]  W. Leslie,et al.  A randomized comparison of radioiodine doses in Graves' hyperthyroidism. , 2003, The Journal of clinical endocrinology and metabolism.

[250]  C. Emerson,et al.  Euthyroid hyperthyroxinemia and thyroxine-binding prealbumin excess in islet cell carcinoma. , 1985, The Journal of clinical endocrinology and metabolism.

[251]  I. Klein Endocrine Disorders and Cardiovascular Disease , 2012 .

[252]  C. Carella,et al.  Clinical review 169: Interferon-alpha-related thyroid disease: pathophysiological, epidemiological, and clinical aspects. , 2004, The Journal of clinical endocrinology and metabolism.

[253]  J. Turner,et al.  LITHIUM AS AN ADJUNCT TO RADIOIODINE THERAPY FOR THYROTOXICOSIS , 1976, The Lancet.

[254]  L. Hegedüs,et al.  The American Thyroid Association/American Association of Clinical Endocrinologists guidelines for hyperthyroidism and other causes of thyrotoxicosis: a European perspective. , 2011, Thyroid : official journal of the American Thyroid Association.

[255]  J. Franklyn,et al.  Mortality after the treatment of hyperthyroidism with radioactive iodine. , 1998, The New England journal of medicine.

[256]  N. Powe,et al.  The importance of surgeon experience for clinical and economic outcomes from thyroidectomy. , 1998, Annals of surgery.

[257]  N. Venkataramana,et al.  Aplasia cutis congenita of the scalp: therapeutic modalities. , 2006, Neurology India.

[258]  K. Burman,et al.  Thyrotoxicosis and thyroid storm. , 2006, Endocrinology and metabolism clinics of North America.

[259]  G. Guyatt,et al.  Grading quality of evidence and strength of recommendations , 2004, BMJ : British Medical Journal.

[260]  Tsukasa Murakami,et al.  Antithyroid drug-induced agranulocytosis. The usefulness of routine white blood cell count monitoring. , 1990, Archives of internal medicine.

[261]  M. Doody,et al.  Cancer mortality following treatment for adult hyperthyroidism. Cooperative Thyrotoxicosis Therapy Follow-up Study Group. , 1998, JAMA.

[262]  D. Glinoer,et al.  The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology. , 1997, Endocrine reviews.

[263]  J. Hamburger Management of hyperthyroidism in children and adolescents. , 1985, The Journal of clinical endocrinology and metabolism.

[264]  N. Takasu,et al.  Remission of Graves' hyperthyroidism predicted by smooth decreases of thyroid-stimulating antibody and thyrotropin-binding inhibitor immunoglobulin during antithyroid drug treatment. , 2000, Thyroid : official journal of the American Thyroid Association.

[265]  J. Garber,et al.  The Role of Propylthiouracil in the Management of Graves' Disease in Adults: report of a meeting jointly sponsored by the American Thyroid Association and the Food and Drug Administration. , 2009, Thyroid : official journal of the American Thyroid Association.

[266]  E. Kulinskaya,et al.  Does smoking increase relapse rates in Graves’ disease? , 2002, Journal of endocrinological investigation.

[267]  J. Boice Radiation and thyroid cancer: what more can be learned? , 1998, Acta oncologica.

[268]  J. Franklyn,et al.  Prevalence and follow‐up of abnormal thyrotrophin (TSH) concentrations in the elderly in the United Kingdom , 1991, Clinical endocrinology.

[269]  J. Boice Radiation-induced thyroid cancer--what's new? , 2005, Journal of the National Cancer Institute.

[270]  C. Reiners,et al.  Radioiodine therapy of Graves' hyperthyroidism: standard vs. calculated 131 iodine activity * . Results from a prospective, randomized, multicentre study , 1995, European journal of clinical investigation.

[271]  E. Torres Vela,et al.  Graves' ophthalmopathy after subtotal thyroidectomy and radioiodine therapy. , 1993, The British journal of surgery.

[272]  I. Klein,et al.  Beta-Adrenergic Receptor Blocking Drugs in the Management of Hyperthyroidism , 1994 .

[273]  O. Clark Total thyroidectomy: the preferred option for multinodular goiter. , 1988, Annals of surgery.

[274]  N. Amino,et al.  Postpartum autoimmune thyroid syndrome: a model of aggravation of autoimmune disease. , 1999, Thyroid : official journal of the American Thyroid Association.

[275]  J. Fradkin,et al.  Iodide‐Induced Thyrotoxicosis , 1983, Lancet.

[276]  H. Gharib,et al.  AACE / AME / ETA Guidelines AMERICAN ASSOCIATION Of ClINICAl ENDOCRINOlOgISTS , ASSOCIAzIONE MEDICI ENDOCRINOlOgI , AND EuROPEAN ThyROID ASSOCIATION MEDICAl guIDElINES fOR ClINICAl PRACTICE fOR ThE DIAgNOSIS AND MANAgEMENT Of ThyROID NODulES , 2010 .

[277]  S. Mandel,et al.  Therapy Insight: management of Graves' disease during pregnancy , 2007, Nature Clinical Practice Endocrinology &Metabolism.

[278]  A. Baker,et al.  Consent and anaesthetic risk , 2003, Anaesthesia.

[279]  Paolo Vitti,et al.  American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and EuropeanThyroid Association Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules. , 2010, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[280]  L. Degroot,et al.  Treatment of Graves' disease and the course of ophthalmopathy. , 1989, The American journal of medicine.

[281]  C. Reasner,et al.  Pattern of recovery of the hypothalamic-pituitary-thyroid axis following radioactive iodine therapy in patients with Graves' disease. , 1995, The American journal of medicine.

[282]  P. Yeo,et al.  Interferon-α Induced Thyroid Dysfunction: Three Clinical Presentations and a Review of the Literature , 1997 .

[283]  M. Hier,et al.  Cost savings associated with post-thyroidectomy parathyroid hormone levels , 2008, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[284]  I. Hart,et al.  Follow-up of solitary autonomous thyroid nodules treated with 131I. , 1983, The New England journal of medicine.

[285]  A. Pinchera,et al.  Low serum thyroglobulin as a clue to the diagnosis of thyrotoxicosis factitia. , 1982, The New England journal of medicine.

[286]  M. Waseem,et al.  Successful outcome with methimazole and lithium combination therapy for propylthiouracil-induced hepatotoxicity. , 1998, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[287]  G. Gavaruzzi,et al.  Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism. , 1993, The Journal of clinical endocrinology and metabolism.

[288]  H. Burch,et al.  Thyroid cancer yield in patients with Graves' disease. , 2003, Minerva endocrinologica.

[289]  R. Kloos,et al.  Evaluation of various doses of recombinant human thyrotropin in patients with multinodular goiters. , 2008, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[290]  W Harry Hannon,et al.  Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). , 2002, The Journal of clinical endocrinology and metabolism.

[291]  Bethany J Figg,et al.  National Institute of Child Health and Human Development , 2013 .

[292]  M. Mcdermott,et al.  Radioiodine-induced thyroid storm. Case report and literature review. , 1983, The American journal of medicine.

[293]  S. Rivkees,et al.  Propylthiouracil (PTU) Hepatoxicity in Children and Recommendations for Discontinuation of Use , 2009, International journal of pediatric endocrinology.

[294]  P. Larsen,et al.  High dose of (131)I therapy for the treatment of hyperthyroidism caused by Graves' disease. , 2002, The Journal of clinical endocrinology and metabolism.

[295]  J. Greenhouse,et al.  Graves' disease: an analysis of thyroid hormone levels and hyperthyroid signs and symptoms. , 1989, The American journal of medicine.

[296]  S. Mezitis,et al.  A case of acute suppurative thyroiditis complicated by thyrotoxicosis , 2006, Journal of endocrinological investigation.

[297]  J. Hershman The role of human chorionic gonadotropin as a thyroid stimulator in normal pregnancy. , 2008, The Journal of clinical endocrinology and metabolism.

[298]  M. Hier,et al.  Predicting Calcium Status Post Thyroidectomy with Early Calcium Levels , 2002, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[299]  J. C. M. van der Vijver,et al.  Recurrence of hyperthyroidism in multinodular goiter after long-term drug therapy: A comparison with Graves’ disease , 1992, Journal of endocrinological investigation.

[300]  N. Boon,et al.  Thyroid disease and the heart , 2000, Heart.

[301]  V. Sridama,et al.  Proptosis in normal Thai samples and thyroid patients. , 2007, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[302]  D. Parmeggiani,et al.  Percutaneous ethanol injection of hyperfunctioning thyroid nodules: long-term follow-up in 125 patients. , 2008, AJR. American journal of roentgenology.

[303]  M. Erdoğan,et al.  A stepwise approach to the treatment of amiodarone-induced thyrotoxicosis. , 2003, Thyroid : official journal of the American Thyroid Association.

[304]  F. Frattaroli,et al.  Total compared with subtotal thyroidectomy in benign nodular disease: personal series and review of published reports. , 2003, The European journal of surgery = Acta chirurgica.

[305]  P. Hall,et al.  Cancer risk after iodine-131 therapy for hyperthyroidism. , 1991, Journal of the National Cancer Institute.

[306]  M. Salvatori,et al.  Diagnostic imaging in thyrotoxicosis. , 1999, Rays.

[307]  R. W. Miller,et al.  Treatment of lymphocytic thyroiditis with spontaneously resolving hyperthyroidism (silent thyroiditis). , 1982, Archives of internal medicine.

[308]  A. Taube,et al.  Thyroid-associated ophthalmopathy after treatment for Graves' hyperthyroidism with antithyroid drugs or iodine-131. , 2009, The Journal of clinical endocrinology and metabolism.

[309]  Faber,et al.  Normalization of serum thyrotrophin by means of radioiodine treatment in subclinical hyperthyroidism: effect on bone loss in postmenopausal women , 1998, Clinical endocrinology.

[310]  D. Cooper Propylthiouracil levels in hyperthyroid patients unresponsive to large doses. Evidence of poor patient compliance. , 1985, Annals of internal medicine.

[311]  S. Yamashita,et al.  The American Thyroid Association and American Association of Clinical Endocrinologists hyperthyroidism and other causes of thyrotoxicosis guidelines: viewpoints from Japan and Korea. , 2011, Thyroid : official journal of the American Thyroid Association.

[312]  C. Sawin,et al.  Low Serum Thyrotropin (Thyroid Stimulating Hormone) in Older Persons without Hyperthyroidism , 1992 .

[313]  E. Landaw,et al.  Hyperthyroidism in children treated with long term medical therapy: twenty-five percent remission every two years. , 1987, The Journal of clinical endocrinology and metabolism.

[314]  A. Miyauchi,et al.  Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease. , 2007, The Journal of clinical endocrinology and metabolism.

[315]  I. Klein,et al.  Effects of amiodarone therapy on thyroid function , 2010, Nature Reviews Endocrinology.

[316]  C. Carella,et al.  Interferon-α-Related Thyroid Disease: Pathophysiological, Epidemiological, and Clinical Aspects , 2004 .

[317]  B Nygaard,et al.  Observer variation in the clinical and laboratory evaluation of patients with thyroid dysfunction and goiter. , 1998, Thyroid : official journal of the American Thyroid Association.

[318]  G. Guyatt,et al.  Grading strength of recommendations and quality of evidence in clinical guidelines: report from an american college of chest physicians task force. , 2006, Chest.

[319]  A. Avenell,et al.  Antithyroid drug regimen for treating Graves' hyperthyroidism. , 2005, The Cochrane database of systematic reviews.

[320]  Douglas L. Mann,et al.  Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine. 8th edition , 2018 .

[321]  M. Aguilar-Diosdado,et al.  Concomitant Agranulocytosis and Hepatotoxicity After Treatment with Carbimazole , 2006, The Annals of pharmacotherapy.

[322]  G. Paz-Filho,et al.  Thiamazole as an adjuvant to radioiodine for volume reduction of multinodular goiter , 2008, Expert opinion on investigational drugs.

[323]  S. Rivkees,et al.  Ending propylthiouracil-induced liver failure in children. , 2009, The New England journal of medicine.

[324]  A. Kung,et al.  Hyperthyroidism during pregnancy due to coexistence of struma ovarii and Graves' disease. , 1990, Postgraduate medical journal.

[325]  P. Hall,et al.  Mortality in patients treated for hyperthyroidism with iodine-131. , 1993, Acta endocrinologica.

[326]  M. Cappa,et al.  Influence of gender and pubertal stage at diagnosis on growth outcome in childhood thyrotoxicosis: results of a collaborative study , 2006, Clinical endocrinology.

[327]  R. Janssen,et al.  An outbreak of thyrotoxicosis caused by the consumption of bovine thyroid gland in ground beef. , 1987, The New England journal of medicine.

[328]  Samuel Wann,et al.  [Guidelines for the management of patients with atrial fibrillation. Executive summary]. , 2006, Revista espanola de cardiologia.

[329]  E. Atkinson,et al.  Clinical features and outcome of subacute thyroiditis in an incidence cohort: Olmsted County, Minnesota, study. , 2003, The Journal of clinical endocrinology and metabolism.

[330]  N. Ishikawa,et al.  Effects of propylthiouracil and methimazole on fetal thyroid status in mothers with Graves' hyperthyroidism. , 1997, The Journal of clinical endocrinology and metabolism.

[331]  Y. Greenman Thyrotrophin-Secreting Pituitary Tumors , 2011 .

[332]  G. Sheline,et al.  Thyroid nodules occurring late after treatment of thyrotoxicosis with radioiodine. , 1962, The Journal of clinical endocrinology and metabolism.

[333]  B. M. Dobyns Prevention and management of hyperthyroid storm , 1978, World journal of surgery.

[334]  D. Wyatt,et al.  Effective Methimazole Dose for Childhood Graves' Disease and Use of Free Triiodothyronine Combined with Concurrent Thyroid Stimulating Hormone Level to Identify Mild Hyperthyroidism and Delayed Pituitary Recovery , 2005, Journal of pediatric endocrinology & metabolism : JPEM.

[335]  W. Duqoum Appendicitis in pregnancy. , 2001, Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit.

[336]  P. Hall,et al.  Cancer mortality after iodine‐131 therapy for hyperthyroidism , 1992, International journal of cancer.

[337]  L. Fleisher Risk of Anesthesia , 2010 .

[338]  R. Segal,et al.  Thyrocardiac disease and its management with radioactive iodine I-131. , 1961, JAMA.

[339]  P. Yeo,et al.  Interferon-alpha induced thyroid dysfunction: three clinical presentations and a review of the literature. , 1997, Thyroid : official journal of the American Thyroid Association.

[340]  A. Stagnaro-Green,et al.  Clinical review 152: Postpartum thyroiditis. , 2002, The Journal of clinical endocrinology and metabolism.

[341]  L. Kovács,et al.  The efficacy of long term thyrostatic treatment in elderly patients with toxic nodular goitre compared to radioiodine therapy with different doses. , 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[342]  P. Laurberg,et al.  TSH‐receptor antibody measurement for differentiation of hyperthyroidism into Graves' disease and multinodular toxic goitre: a comparison of two competitive binding assays , 2001, Clinical endocrinology.

[343]  S. Roman,et al.  A population-based study of outcomes from thyroidectomy in aging Americans: at what cost? , 2008, Journal of the American College of Surgeons.

[344]  D. Wing,et al.  Low birth weight and preeclampsia in pregnancies complicated by hyperthyroidism , 1995 .

[345]  M. Surks,et al.  Serum thyrotropin measurements in the community: five-year follow-up in a large network of primary care physicians. , 2007, Archives of internal medicine.

[346]  N. Kamel,et al.  Prevalence and clinical significance of antineutrophil cytoplasmic antibody in Graves’ patients treated with propylthiouracil , 2009, International journal of clinical practice.

[347]  P. Czernichow,et al.  Predictors of autoimmune hyperthyroidism relapse in children after discontinuation of antithyroid drug treatment. , 2008, The Journal of clinical endocrinology and metabolism.

[348]  H. Röher,et al.  [Complications in thyroid surgery. Incidence and therapy]. , 1999, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen.

[349]  R. Jorde,et al.  Prevalence and causes of undiagnosed hyperthyroidism in an adult healthy population. The Tromsø study , 2008, Journal of endocrinological investigation.

[350]  J. Konishi,et al.  Metastatic thyroid cancer presenting as thyrotoxicosis: report of three cases , 1994, Clinical endocrinology.

[351]  Mathew R. Williams,et al.  Thyroidectomy using local anesthesia in critically ill patients with amiodarone-induced thyrotoxicosis: a review and description of the technique. , 2002, Thyroid : official journal of the American Thyroid Association.

[352]  P. Perros,et al.  A prospective study of the effects of radioiodine therapy for hyperthyroidism in patients with minimally active graves' ophthalmopathy. , 2005, The Journal of clinical endocrinology and metabolism.

[353]  K. Woeber Methimazole-induced hepatotoxicity. , 2002, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[354]  O. Clark,et al.  The optimal treatment for pediatric Graves' disease is surgery. , 2007, The Journal of clinical endocrinology and metabolism.

[355]  S. Rivkees,et al.  Adverse Events Associated with Methimazole Therapy of Graves' Disease in Children , 2010, International journal of pediatric endocrinology.

[356]  J. Romaldini,et al.  The effects of early antithyroid therapy for endogenous subclinical hyperthyroidism in clinical and heart abnormalities. , 2003, The Journal of clinical endocrinology and metabolism.

[357]  S. Roman,et al.  Pediatric endocrine surgery: who is operating on our children? , 2008, Surgery.

[358]  G S Levey,et al.  Treatment of Hyperthyroid Disease , 1994, Annals of Internal Medicine.

[359]  Y. Liaw,et al.  Hepatic Injury during Propylthiouracil Therapy in Patients with Hyperthyroidism: A Cohort Study , 1993, Annals of Internal Medicine.

[360]  M. Eckman,et al.  Radioiodine or surgery for toxic thyroid adenoma: dissecting an important decision. A cost-effectiveness analysis. , 2004, Thyroid : official journal of the American Thyroid Association.

[361]  M. Inaba,et al.  Persistent increase in bone turnover in Graves' patients with subclinical hyperthyroidism. , 2000, The Journal of clinical endocrinology and metabolism.

[362]  F. Cunningham,et al.  Thyrotoxicosis complicating pregnancy , 1989, American journal of obstetrics and gynecology.

[363]  H. Bank,et al.  Propylthiouracil-induced hepatic damage. , 1980, Archives of internal medicine.

[364]  L. Wartofsky,et al.  Life-threatening thyrotoxicosis. Thyroid storm. , 1993, Endocrinology and metabolism clinics of North America.

[365]  K. Kaufman,et al.  The impact of overt and subclinical hyperthyroidism on skeletal muscle. , 2006, Thyroid : official journal of the American Thyroid Association.

[366]  J. Dötsch,et al.  Diagnosis and Management of Juvenile Hyperthyroidism in Germany: A Retrospective Multicenter Study , 2000, Journal of pediatric endocrinology & metabolism : JPEM.

[367]  S. Skeie,et al.  Predictors of outcome and comparison of different drug regimens for the prevention of relapse in patients with Graves' disease. , 2002, European journal of endocrinology.

[368]  P. Laurberg,et al.  A longitudinal study of serum TSH, and total and free iodothyronines during normal pregnancy. , 1982, Acta endocrinologica.

[369]  R. B. Wilcox,et al.  The nature of analogue-based free thyroxine estimates. , 2004, Thyroid : official journal of the American Thyroid Association.

[370]  A. Pinchera,et al.  Comparison of radioiodine with radioiodine plus lithium in the treatment of Graves' hyperthyroidism. , 1999, The Journal of clinical endocrinology and metabolism.

[371]  S. Rivkees,et al.  Clinical review 99: The management of Graves' disease in children, with special emphasis on radioiodine treatment. , 1998, The Journal of clinical endocrinology and metabolism.

[372]  Scott Davis,et al.  Thyroid neoplasia, autoimmune thyroiditis, and hypothyroidism in persons exposed to iodine 131 from the hanford nuclear site. , 2004, JAMA.

[373]  J. Benichou,et al.  Genetic and Clinical Features of 42 Kindreds with Resistance to Thyroid Hormone: The National Institutes of Health Prospective Study , 1995, Annals of Internal Medicine.

[374]  R. Mortimer,et al.  Graves'DISEASE IN PREGNANCY: TSH RECEPTOR BINDING INHIBITING IMMUNOGLOBULINS AND MATERNAL AND NEONATAL THYROID FUNCTION , 1990, Clinical endocrinology.

[375]  H. Gharib,et al.  American Association of Clinical Endocrinologists Protocol for Standardized Production of Clinical Practice Guidelines--2010 update. , 2010, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.